Haplotype analysis of 94 cystic fibrosis mutations with seven polymorphic CFTR DNA markers

被引:0
作者
Morral, N
Dork, T
Llevadot, R
Dziadek, V
Mercier, B
Ferec, C
Costes, B
Girodon, E
Zielenski, J
Tsui, LC
Tummler, B
Estivill, X
机构
[1] INST CANC RES,DEPT MOL GENET,BARCELONA 08907,CATALUNYA,SPAIN
[2] HANNOVER MED SCH,KLIN FORSCH GRP,D-30625 HANNOVER,GERMANY
[3] CTR TRANSFUS SANGUINE & BIOGENET,F-29275 BREST,FRANCE
[4] INSERM,U91,CNRS,UA 607,UNIT RECH GENET MOL & HEMATOL,F-94010 CRETEIL,FRANCE
[5] HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA
关键词
cystic fibrosis; haplotypes; mutation screening;
D O I
10.1002/(SICI)1098-1004(1996)8:2<149::AID-HUMU7>3.0.CO;2-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We have analyzed 416 normal and 467 chromosomes carrying 94 different cystic fibrosis (CF) mutations with polymorphic genetic markers J44, IVS6aGATT, IVS8CA, T854, IVS17BTA, IVS 17BCA, and TUB20. The number of mutations found with each haplotype is proportional to its frequency among normal chromosomes, suggesting that there is no preferential haplotype in which mutations arise and thus excluding possible selection for specific haplotypes. While many common mutations in the worldwide CF population showed absence of haplotype variation, indicating their recent origins, some mutations were associated with more than one haplotype. The most common CF mutations, Delta F508, G542X, and N1303K, showed the highest number of slippage events at microsatellites, suggesting that they are the most ancient CF mutations. Recurrence was probably the case for 9 CF mutations (R117H, H199Y, R347YH, R347P, L558S, 2184insA, 3272-26A-->G, R1162X, and 3849 + 10kbC-->T). This analysis of 94 CF mutations should facilitate mutation screening and provides useful data for studies on population genetics of CF. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:149 / 159
页数:11
相关论文
共 73 条
[1]  
ABELIOVICH D, 1992, AM J HUM GENET, V51, P951
[2]   IDENTIFICATION OF 12 NOVEL MUTATIONS IN THE CFTR GENE [J].
AUDREZET, MP ;
MERCIER, B ;
GUILLERMIT, H ;
QUERE, I ;
VERLINGUE, C ;
RAULT, G ;
FEREC, C .
HUMAN MOLECULAR GENETICS, 1993, 2 (01) :51-54
[3]   IDENTIFICATION OF 4 NEW MUTATIONS IN THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE - I148T, L1077P, Y1092X, 2183AA-]G [J].
BOZON, D ;
ZIELENSKI, J ;
RININSLAND, F ;
TSUI, LC .
HUMAN MUTATION, 1994, 3 (03) :330-332
[4]   MUTATION AND LINKAGE DISEQUILIBRIUM ANALYSIS IN GENETIC-COUNSELING OF SPANISH CYSTIC-FIBROSIS FAMILIES [J].
CASALS, T ;
NUNES, V ;
LAZARO, C ;
GIMENEZ, FJ ;
GIRBAU, E ;
VOLPINI, V ;
ESTIVILL, X .
JOURNAL OF MEDICAL GENETICS, 1991, 28 (11) :771-776
[5]   DIRECT SEQUENCING OF THE COMPLETE CFTR GENE - THE MOLECULAR CHARACTERIZATION OF 99.5-PERCENT OF CF CHROMOSOMES IN WALES [J].
CHEADLE, JP ;
GOODCHILD, MC ;
MEREDITH, AL .
HUMAN MOLECULAR GENETICS, 1993, 2 (10) :1551-1556
[6]  
CHEHAB EF, 1991, AM J HUM GENET, V48, P223
[7]  
CHILLON M, 1994, HUM GENET, V93, P447
[8]  
CHILLON M, 1995, AM J HUM GENET, V56, P623
[9]   IDENTIFICATION OF A NEW MISSENSE MUTATION (P205S) IN THE 1ST TRANSMEMBRANE DOMAIN OF THE CFTR GENE ASSOCIATED WITH A MILD CYSTIC-FIBROSIS PHENOTYPE [J].
CHILLON, M ;
CASALS, T ;
NUNES, V ;
GIMENEZ, J ;
RUIZ, EP ;
ESTIVILL, X .
HUMAN MOLECULAR GENETICS, 1993, 2 (10) :1741-1742
[10]   IDENTIFICATION OF A 31-BP INSERTION (3860INS31) IN EXON-20 OF THE CYSTIC-FIBROSIS (CFTR) GENE [J].
CHILLON, M ;
CASALS, T ;
NUNES, V ;
GIMENEZ, J ;
ESTIVILL, X .
HUMAN MOLECULAR GENETICS, 1993, 2 (08) :1317-1318